Crossmark

The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer

Crossref DOI link: https://doi.org/10.1007/s12094-022-02957-x

Published Online: 2022-10-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Liuxun https://orcid.org/0000-0001-9762-4183
Xu, Jiangli https://orcid.org/0000-0002-1331-440X
Funding

Funding for this research was provided by:

China Sponsorship Council (201708430104)
License Information

Text and Data Mining valid from 2022-10-06

Version of Record valid from 2022-10-06
More Information

Article History

Received: 22 June 2022

Accepted: 15 September 2022

First Online: 6 October 2022

Declarations

:

: The authors have not disclosed any conflict of interests.

: It is not applicable.

: It is not applicable.

Document is current

Any future updates will be listed below